DIM200 200 mg by Evlution Nutrition — Ingredients, Evidence & Safety

Product Label

📄 Open Full PDF View on NIH DSLD →

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Capsule(s) Serving Size

60 Servings

Other Combinations Product Type

50% Evidence Coverage

Supplement Facts — Evidence Check

Diindolylmethane

200 mg

📊 Market median: 200.0mg (3 products) 📚 10 studies (Tier A: 1, B: 3)

This product: 200mg

Bioperine

2.5 mg

Other Ingredients

Rice Flour Cellulose Stearate Silicon Dioxide

Label Claims — Verification

❓ All Other

❓ Structure/Function

All Other (96% of products) Structure/Function (88% of products) Nutrient (2% of products) No Claim (1% of products)

Target Groups

Vegan Vegetarian Adult (18 - 50 Years) Women (not pregnant or lactating) Dairy Free

Product Information

📋 Directions for Use

Suggested use: As a dietary supplement, take 1 capsule daily, preferably with a meal or as recommended by a physician.

⚠️ Warnings & Precautions

Warning: Not for use by those under the age of 18.

Do not use if you are nursing or pregnant.

Keep out of reach of children and pets.

🧪 Formulation Notes

DIM200 key product features: 200 mg Dindolylmethane (DIM) 2.5 mg BioPerine for absorption

Supports balanced hormone levels

Vegan/Non-GMO

This product is made in the USA, has been distributed and manufactured by a (GMP) registered facility and contains ingredients of domestic and international origin.

Additional Information

Store product at room temperature. Do not expose to excessive heat or moisture.

Instagram Facebook Twitter @EVLSports #EVL

Made in the USA

Product Details

UPC / SKU 8 18901 02704 6

DSLD Entry Date 2024-01-24

Product Type Other Combinations

Form Capsule

Brand Evlution Nutrition

DSLD ID 302096

Data Updated 2026-04-11

Research Evidence

5 Research Sources

44 Avg Quality Score

5 Rct

C A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen

Rct Breast cancer research and treatment 2017

PubMed DOI

C Phase Ib placebo-controlled, tissue biomarker trial of diindolylmethane (BR-DIMNG) in patients with prostate cancer who are undergoing prostatectomy

Rct European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2016

PubMed DOI

C Effectiveness of 3,3'-Diindolylmethane Supplements on Favoring the Benign Estrogen Metabolism Pathway and Decreasing Body Fat in Premenopausal Women

Rct Nutrition and cancer 2023

PubMed DOI

C The effects of light exposure on the cortisol stress response in human males.

Rct Stress (Amsterdam, Netherlands)

PubMed DOI

D Pilot study: effect of 3,3'-diindolylmethane supplements on urinary hormone metabolites in postmenopausal women with a history of early-stage breast cancer

Rct Nutrition and cancer 2004

PubMed

View all evidence for Dim →